Tradename | Company | Number | Date | Products |
---|---|---|---|---|
BEVESPI AEROSPHERE | AstraZeneca | N-208294 RX | 2016-04-25 | 1 products, RLD, RS |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
BREZTRI AEROSPHERE | AstraZeneca | N-212122 RX | 2020-07-23 | 1 products, RLD, RS |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
ROBINUL | Casper Pharma | N-012827 RX | 1982-01-01 | 1 products, RLD |
ROBINUL FORTE | Casper Pharma | N-012827 RX | 1982-01-01 | 1 products, RLD |
GLYRX-PF | Exela Pharma Sciences | N-210997 RX | 2018-07-11 | 3 products, RLD, RS |
GLYCOPYRROLATE | Fresenius Kabi | N-214919 RX | 2022-04-21 | 1 products, RLD, RS |
CUVPOSA | Merz | N-022571 RX | 2010-07-28 | 1 products, RLD, RS |
Brand Name | Status | Last Update |
---|---|---|
bevespi aerosphere | New Drug Application | 2023-03-24 |
bretzri | New Drug Application | 2020-07-23 |
breztri | New Drug Application | 2022-01-26 |
cuvposa | New Drug Application | 2024-12-19 |
dartisla odt | New Drug Application | 2023-10-19 |
glycate | ANDA | 2024-01-17 |
glycopyrrolate | ANDA | 2025-01-08 |
glycopyrrolate 1ml | ANDA | 2023-10-23 |
glycopyrrolate oral solution | ANDA | 2024-01-17 |
glyrx-pf | New Drug Application | 2018-08-01 |
Patent | Expires | Flag | FDA Information |
---|---|---|---|
Glycopyrrolate / Neostigmine Methylsulfate, Prevduo, Azurity | |||
10456354 | 2038-10-25 | DP | |
11110054 | 2038-10-25 | DP | |
Budesonide / Formoterol Fumarate / Glycopyrrolate, Breztri Aerosphere, Astrazeneca Ab | |||
11331442 | 2038-10-05 | DP | |
11833292 | 2038-10-05 | DP | |
8815258 | 2031-03-17 | U-2889 | |
8324266 | 2030-05-28 | U-2889 | |
8703806 | 2030-05-28 | U-2889 | |
8808713 | 2030-05-28 | DP | U-2889 |
9415009 | 2030-05-28 | U-2889 | |
9463161 | 2030-05-28 | DP | U-2889 |
10716753 | 2030-05-28 | DP | U-2889 |
Glycopyrrolate, Lonhala Magnair Kit, Sumitomo Pharma Am | |||
10744277 | 2036-12-07 | DP | U-2941 |
10688518 | 2036-11-12 | DP | |
10376661 | 2035-09-14 | DP | |
9604018 | 2033-05-16 | DP | |
9168556 | 2032-09-01 | DP | |
9789270 | 2030-10-30 | DP | |
10940110 | 2029-02-26 | DP | U-1773 |
9265900 | 2028-12-07 | DP | |
11278683 | 2026-08-16 | DP | |
7931212 | 2025-11-25 | DP | |
7458372 | 2024-11-18 | DP | |
Glycopyrrolate, Seebri, Novartis | |||
8182838 | 2028-10-20 | DP | |
8479730 | 2028-10-11 | DP | |
Glycopyrrolate / Indacaterol Maleate, Utibron, Novartis | |||
6878721 | 2025-02-25 | DS, DP | U-1773 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Chronic obstructive pulmonary disease | D029424 | EFO_0000341 | J44.9 | 7 | 6 | 7 | 1 | 3 | 23 |
Asthma | D001249 | EFO_0000270 | J45 | 4 | 2 | 2 | 1 | 3 | 12 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Obstructive lung diseases | D008173 | — | — | 5 | 5 | 6 | — | 3 | 18 |
Lung diseases | D008171 | EFO_0003818 | J98.4 | — | 3 | 5 | — | 1 | 9 |
Disease progression | D018450 | — | — | — | — | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Covid-19 | D000086382 | — | U07.1 | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Healthy volunteers/patients | — | — | — | 1 | — | — | — | — | 1 |
Respiratory aspiration | D053120 | EFO_1001839 | — | 1 | — | — | — | — | 1 |
Drug common name | Glycopyrrolate |
INN | glycopyrronium bromide |
Description | 2-cyclopentyl-2-hydroxy-2-phenylacetic acid (1,1-dimethyl-3-pyrrolidin-1-iumyl) ester is a member of benzenes. |
Classification | Small molecule |
Drug class | Antimuscarinic agent |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | C[N+]1(C)CCC(OC(=O)C(O)(c2ccccc2)C2CCCC2)C1.[Br-] |
PDB | — |
CAS-ID | 596-51-0 |
RxCUI | — |
ChEMBL ID | CHEMBL1201027 |
ChEBI ID | — |
PubChem CID | 3494 |
DrugBank | DBSALT001183 |
UNII ID | V92SO9WP2I (ChemIDplus, GSRS) |